Crossmark

OSA Endotypes: What Are They and What Are Their Potential Clinical Implications?

Crossref DOI link: https://doi.org/10.1007/s40675-018-0121-8

Published Online: 2018-07-03

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmickl, Christopher N.

Owens, Robert L.

Edwards, Bradley A.

Malhotra, Atul
License Information

Text and Data Mining valid from 2018-07-03
More Information

Article History

First Online: 3 July 2018

Compliance with Ethical Standards

:

: Christopher N. Schmickl declares no conflicts of interest.Robert L. Owens reports personal fees from Novartis, personal fees from ResMed, personal fees from Itamar.Bradley A. Edwards grants from Heart Foundation of Australia.Atul Malhotra relinquished all outside personal income in 2012 as an Officer of the American Thoracic Society. Resmed provided a philanthropic donation to the UC San Diego in support of a sleep center.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: Robert L. Owens is supported by NHLBI R01 HL142114–01. Bradley A. Edwards is supported by a Heart Foundation of Australia Future Leader Fellowship (101167).